Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Exact Sciences Corporation (EXAS)

  • SEC News
  • Oct. 24, 2025, 15:08 UTC
  • 0
  • 1 comments

📋 Zanotti Katherine S (Director) plans to sell 12K shares of EXACT SCIENCES CORP (at $65.00 each, total $780K) Filed: Oct 24, 2025 | ID: 006543

Comment Full text

Astria Therapeutics Inc. (ATXS)

  • SEC News
  • Oct. 24, 2025, 15:01 UTC
  • 0
  • 0 comments

New Form SCHEDULE 13D - Astria Therapeutics, Inc. Filed: 2025-10-24 AccNo: 0001104659-25-102037 Size: 70 KB

Comment Full text

Scworx Corp (WORX)

  • SEC News
  • Oct. 24, 2025, 13:45 UTC
  • 0
  • 0 comments

New Form DEF 14A - SCWorx Corp. Filed: 2025-10-24 AccNo: 0001213900-25-101937 Size: 842 KB

Comment Full text

Thermo Fisher Scientific Inc (TMO)

  • SEC News
  • Oct. 24, 2025, 13:41 UTC
  • 0
  • 1 comments

📋 Pettiti Gianluca (Officer) plans to sell 400 shares of THERMO FISHER SCIENTIFIC INC. (at $574.15 each, total $230K) Filed: Oct 24, 2025 | ID: 006538

Comment Full text

Adverum Biotechnologies Inc (ADVM)

  • SEC News
  • Oct. 24, 2025, 13:27 UTC
  • 0
  • 0 comments

New Form SC14D9C - Adverum Biotechnologies, Inc. Filed: 2025-10-24 AccNo: 0001193125-25-249440 Size: 243 KB

Comment Full text

Adverum Biotechnologies Inc (ADVM)

  • SEC News
  • Oct. 24, 2025, 13:19 UTC
  • 0
  • 1 comments

(90% Positive) Adverum Biotechnologies, Inc. (ADVM) Announces Business Combination

Comment Full text

Akari Therapeutics plc (AKTX)

  • SEC News
  • Oct. 24, 2025, 13:18 UTC
  • 0
  • 1 comments

Farag Kameel D. 🟢 acquired 6.3K shares of Akari Therapeutics Plc (AKTX) at $0.74 Transaction Date: Oct 22, 2025 | Filing ID: 019194

Comment Full text

GSK plc (GLAXF)

  • SEC News
  • Oct. 24, 2025, 13:16 UTC
  • 0
  • 0 comments

New Form 6-K - GSK plc Filed: 2025-10-24 AccNo: 0001654954-25-012176 Size: 69 KB

Comment Full text

Akari Therapeutics plc (AKTX)

  • SEC News
  • Oct. 24, 2025, 13:16 UTC
  • 0
  • 0 comments

New Form 3 - Akari Therapeutics Plc Filed: 2025-10-24 AccNo: 0001493152-25-019192 Size: 12 KB

Comment Full text

Premier Inc (PINC)

  • SEC News
  • Oct. 24, 2025, 12:58 UTC
  • 0
  • 0 comments

New Form 10-K/A - Premier, Inc. Filed: 2025-10-24 AccNo: 0001577916-25-000015 Size: 2 MB

Comment Full text
  • 1
  • 2
  • 3
  • Next

Search

News categories

  • Technical Exchange News(10264)
  • Event(1436)
  • SEC News(174039)
  • FDA Approval(9602)
  • Company Report(721)
  • Business News(116861)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin